TCR2 THERAPEUTICS INC.

Home » TCR2 THERAPEUTICS INC.

IPO

TCR2 THERAPEUTICS INC.

We are an innovative immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer

Symbol

TCRR

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Effective Date
February 14, 2019

Underwriters
Jefferies, Leerink Partners, BMO Capital Markets, Wedbush PacGrow, China Renaissance

To view the prospectus for TCR2 THERAPEUTICS INC. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253